Bertagna F - Search Results

1

Role of 2-[¹⁸F]FDG as a Radiopharmaceutical for PET/CT in Patients with COVID-19: A Systematic Review.

Annunziata S, Delgado Bolton RC, Kamani CH, Prior JO, Albano D, Bertagna F, Treglia G. Annunziata S, et al. Among authors: bertagna f. Pharmaceuticals (Basel). 2020 Nov 10;13(11):377. doi: 10.3390/ph13110377. Pharmaceuticals (Basel). 2020. PMID: 33182811 Free PMC article. Review.

2

[¹⁸F]FDG-PET/CT in patients affected by retroperitoneal fibrosis: a bicentric experience.

Bertagna F, Treglia G, Leccisotti L, Bosio G, Motta F, Giordano A, Giubbini R. Bertagna F, et al. Jpn J Radiol. 2012 Jun;30(5):415-21. doi: 10.1007/s11604-012-0066-7. Epub 2012 Mar 16. Jpn J Radiol. 2012. PMID: 22421932

3

Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas.

Bertagna F, Treglia G, Piccardo A, Giubbini R. Bertagna F, et al. J Clin Endocrinol Metab. 2012 Nov;97(11):3866-75. doi: 10.1210/jc.2012-2390. Epub 2012 Aug 17. J Clin Endocrinol Metab. 2012. PMID: 22904176 Review.

4

Diagnostic performance of Fluorine-18-Fluorodeoxyglucose positron emission tomography in patients with chronic inflammatory bowel disease: a systematic review and a meta-analysis.

Treglia G, Quartuccio N, Sadeghi R, Farchione A, Caldarella C, Bertagna F, Fania P, Cistaro A. Treglia G, et al. Among authors: bertagna f. J Crohns Colitis. 2013 Jun;7(5):345-54. doi: 10.1016/j.crohns.2012.08.005. Epub 2012 Sep 7. J Crohns Colitis. 2013. PMID: 22960135 Review.

5

Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with neurofibromatosis type 1: a systematic review.

Treglia G, Taralli S, Bertagna F, Salsano M, Muoio B, Novellis P, Vita ML, Maggi F, Giordano A. Treglia G, et al. Among authors: bertagna f. Radiol Res Pract. 2012;2012:431029. doi: 10.1155/2012/431029. Epub 2012 Sep 9. Radiol Res Pract. 2012. PMID: 22991664 Free PMC article.

6

Fluorine-18-fluorodeoxyglucose positron emission tomography in assessing retroperitoneal fibrosis: a literature review.

Treglia G, Mattoli MV, Bertagna F. Treglia G, et al. Among authors: bertagna f. Int J Mol Imaging. 2012;2012:484052. doi: 10.1155/2012/484052. Epub 2012 Sep 25. Int J Mol Imaging. 2012. PMID: 23050140 Free PMC article.

7

Emerging role of Fluorine-18-fluorodeoxyglucose positron emission tomography in patients with retroperitoneal fibrosis: a systematic review.

Treglia G, Mattoli MV, Bertagna F, Giubbini R, Giordano A. Treglia G, et al. Among authors: bertagna f. Rheumatol Int. 2013 Mar;33(3):549-55. doi: 10.1007/s00296-012-2576-0. Epub 2012 Nov 5. Rheumatol Int. 2013. PMID: 23124736 Review.

8

F18-FDG-PET/CT thyroid incidentalomas: a wide retrospective analysis in three Italian centres on the significance of focal uptake and SUV value.

Bertagna F, Treglia G, Piccardo A, Giovannini E, Bosio G, Biasiotto G, Bahij el K, Maroldi R, Giubbini R. Bertagna F, et al. Endocrine. 2013 Jun;43(3):678-85. doi: 10.1007/s12020-012-9837-2. Epub 2012 Nov 21. Endocrine. 2013. PMID: 23179777

9

F18-FDG-PET/CT for evaluation of intraductal papillary mucinous neoplasms (IPMN): a review of the literature.

Bertagna F, Treglia G, Baiocchi GL, Giubbini R. Bertagna F, et al. Jpn J Radiol. 2013 Apr;31(4):229-36. doi: 10.1007/s11604-012-0176-2. Epub 2013 Jan 12. Jpn J Radiol. 2013. PMID: 23315020 Review.

10

A thyroid incidentaloma detected by 18F-choline PET/CT.

Treglia G, Giovannini E, Mirk P, Di Franco D, Oragano L, Bertagna F. Treglia G, et al. Among authors: bertagna f. Clin Nucl Med. 2014 Apr;39(4):e267-9. doi: 10.1097/RLU.0b013e3182817d78. Clin Nucl Med. 2014. PMID: 23579984

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

298 results

Search Page